The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 study of EIK1001, a Toll-like receptor 7/8 (TLR7/8) agonist, in combination with pembrolizumab and chemotherapy in patients with stage 4 non-small cell lung cancer.
 
Dan Costin
No Relationships to Disclose
 
Kevin Chen
No Relationships to Disclose
 
Richard J. Gralla
No Relationships to Disclose
 
Brage Garofalo
Employment - Eikon Therapeutics; Simcha Therapeutics
Stock and Other Ownership Interests - Eikon Therapeutics
 
Meihua Wang
Employment - Alkermes; Eikon Therapeutics
Stock and Other Ownership Interests - Alkermes; Eikon Therapeutics
 
Etah Kurland
Employment - Bayer; Eikon Therapeutics
Stock and Other Ownership Interests - Eikon Therapeutics; Pfizer